ClinicalTrials.Veeva

Menu

Mindfulness and Placebo for Pain (MAPP) Study

Arizona State University (ASU) logo

Arizona State University (ASU)

Status

Enrolling

Conditions

Chronic Pain

Treatments

Behavioral: Mindfulness-Based Stress Reduction (MBSR)
Other: MBSR+OLP
Other: Open-Label Placebo (OLP)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06720909
1R34AT012677 (U.S. NIH Grant/Contract)
STUDY00020051

Details and patient eligibility

About

This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate in an 8-week trial, with a subsequent 3-month post-treatment follow-up.

Participants will be randomly assigned to one of the following three conditions:

  1. Mindfulness-Based Stress Reduction (MBSR)
  2. OLP treatment
  3. combination of MBSR and OLP treatment

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. ≥18 years old;
  2. ability to speak, write, and read in English;
  3. physical pain present on at least half the days in the past 3 months; and
  4. average past week pain severity rating ≥3 on a 0-10 Numerical Rating Scale.

Exclusion criteria

  1. acute pain due to recent injury or surgery;
  2. self-reporting of chronic malignant pain (e.g., cancer, HIV);
  3. self-reporting of Raynaud's disease (those who can be contraindicated for cold pressor testing);
  4. severe psychopathology (e.g., a psychotic disorder) or significant cognitive deficits judged to interfere with study procedures;
  5. currently pregnant or breastfeeding;
  6. inability to discontinue use of vitamin B2 supplements or a multivitamin containing vitamin B2 throughout the study period (these interfere with riboflavin tracer-OLP treatment adherence-monitoring);
  7. inability to commit to study period.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 3 patient groups

MBSR-Only
Experimental group
Description:
This experimental arm receives the 8-week MBSR program only.
Treatment:
Behavioral: Mindfulness-Based Stress Reduction (MBSR)
OLP-Only
Experimental group
Description:
This experimental arm receives the OLP treatment only.
Treatment:
Other: Open-Label Placebo (OLP)
MBSR+OLP
Experimental group
Description:
This experimental arm receives the 8-week MBSR program AND the 8-week OLP treatment.
Treatment:
Other: MBSR+OLP

Trial contacts and locations

2

Loading...

Central trial contact

Chung Jung Mun, PhD; Ryan Eckert, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems